Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00610961 · ClinicalTrials.gov registry record
Induction Related BK Viremia in Renal Transplant Patients
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 60
- Enrollment target
NCT00610961 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 60 participants.
The verdict
NCT00610961 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The increase immunosuppression in our transplant population has led to an unacceptable rate of patients at risk for BK virus nephropathy. Reducing induction immunosuppression by switching from Thymoglobulin to Simulect will reduce the incidence of serum positivity for BK by PCR.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00610961
The ClinicalTrials.gov registry entry for NCT00610961 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00610961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00610961 about?
NCT00610961 is a clinical study titled "Induction Related BK Viremia in Renal Transplant Patients". The increase immunosuppression in our transplant population has led to an unacceptable rate of patients at risk for BK virus nephropathy. Reducing induction immunosuppression by switching from Thymoglobulin to Simulect will reduce the incidence of serum positivity for BK by PCR.
What is the current status of trial NCT00610961?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2007-10. Estimated completion is 2009-11.
Who is sponsoring clinical trial NCT00610961?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.